Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Front Med (Lausanne) ; 8: 637885, 2021.
Article in English | MEDLINE | ID: covidwho-1399143

ABSTRACT

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect a broad range of human tissues by using the host receptor angiotensin-converting enzyme 2 (ACE2). Individuals with comorbidities associated with severe COVID-19 display higher levels of ACE2 in the lungs compared to those without comorbidities, and conditions such as cell stress, elevated glucose levels and hypoxia may also increase the expression of ACE2. Here, we showed that patients with Barrett's esophagus (BE) have a higher expression of ACE2 in BE tissues compared to normal squamous esophagus, and that the lower pH associated with BE may drive this increase in expression. Human primary monocytes cultured in reduced pH displayed increased ACE2 expression and higher viral load upon SARS-CoV-2 infection. We also showed in two independent cohorts of 1,357 COVID-19 patients that previous use of proton pump inhibitors is associated with 2- to 3-fold higher risk of death compared to those not using the drugs. Our work suggests that pH has a great influence on SARS-CoV-2 Infection and COVID-19 severity.

2.
Rev. Soc. Bras. Med. Trop ; 53:e20200401-e20200401, 2020.
Article in English | LILACS (Americas) | ID: grc-742847

ABSTRACT

We present postmortem evidence of invasive pulmonary aspergillosis (IPA) in a patient with severe COVID-19. Autopsies of COVID-19 confirmed cases were performed. The patient died despite antimicrobials, mechanical ventilation, and vasopressor support. Histopathology and peripheral blood galactomannan antigen testing confirmed IPA. Aspergillus penicillioides infection was confirmed by nucleotide sequencing and BLAST analysis. Further reports are needed to assess the occurrence and frequency of IPA in SARS-CoV-2 infections, and how they interact clinically.

3.
Rev Soc Bras Med Trop ; 53: e20200401, 2020.
Article in English | MEDLINE | ID: covidwho-636312

ABSTRACT

We present postmortem evidence of invasive pulmonary aspergillosis (IPA) in a patient with severe COVID-19. Autopsies of COVID-19 confirmed cases were performed. The patient died despite antimicrobials, mechanical ventilation, and vasopressor support. Histopathology and peripheral blood galactomannan antigen testing confirmed IPA. Aspergillus penicillioides infection was confirmed by nucleotide sequencing and BLAST analysis. Further reports are needed to assess the occurrence and frequency of IPA in SARS-CoV-2 infections, and how they interact clinically.


Subject(s)
Aspergillus/isolation & purification , Betacoronavirus , Coronavirus Infections/pathology , Invasive Pulmonary Aspergillosis/pathology , Pneumonia, Viral/pathology , Aged , Aspergillus/genetics , Autopsy , COVID-19 , Coronavirus Infections/complications , Fatal Outcome , Humans , Invasive Pulmonary Aspergillosis/complications , Lung/microbiology , Male , Pandemics , Pneumonia, Viral/complications , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL